. Mediator from the yeast Saccharomyces cerevisiae has a molecular mass of 1.4 megadaltons and comprises 25 subunits that form the head, middle, tail and kinase modules [5] [6] [7] . The head module constitutes one-half of the essential Mediator core 8 , and comprises the conserved 9 subunits Med6, Med8, Med11, Med17, Med18, Med20 and Med22. Recent X-ray analysis of the S. cerevisiae head module at 4.3 Å resolution led to a partial architectural model with three submodules called neck, fixed jaw and moveable jaw 10 . Here we determine de novo the crystal structure of the head module from the fission yeast Schizosaccharomyces pombe at 3.4 Å resolution. Structure solution was enabled by new structures of Med6 and the fixed jaw, and previous structures of the moveable jaw 11 and part of the neck 12 , and required deletion of Med20. The S. pombe head module resembles the head of a crocodile with eight distinct elements, of which at least four are mobile. The fixed jaw comprises tooth and nose domains, whereas the neck submodule contains a helical spine and one limb, with shoulder, arm and finger elements. The arm and the essential shoulder contact other parts of Mediator. The jaws and a central joint are implicated in interactions with Pol II and its carboxy-terminal domain, and the joint is required for transcription in vitro. The S. pombe head module structure leads to a revised model of the S. cerevisiae module, reveals a high conservation and flexibility, explains known mutations, and provides the basis for unravelling a central mechanism of gene regulation.
Extending our structural analysis of Mediator 13 , we determined the crystal structure of a bacterially expressed Med6 variant (S. pombe (Sp) residues 9-180) at 2.7 Å resolution (Supplementary Figs 1, 2a and  Supplementary Table 1 ). The structure revealed a core domain with a five-stranded antiparallel b-sheet, two pairs of a-helices flanking a conserved groove, and a flexible C-terminal helix a5 (Fig. 1a, b and Supplementary Fig. 3 ). Bacterial expression also provided the head subcomplex Med17C-Med11C-Med22C, which consists of C-terminal regions in Med17, Med11 and Med22 (ref. 12 ) and constitutes the fixed jaw 10 (see Methods and Supplementary Fig. 2b ). The crystal structure at 3.0 Å resolution (Supplementary Table 1 ) revealed two subdomains we call 'tooth' and 'nose' (Fig. 1c) . The tooth contains Med11C, Med22C and Med17C residues 383-541 and 594-611. It forms a five-stranded b-sheet that is flanked by five helices, three from Med17C and one each from Med11C and Med22C. The nose comprises Med17C residues 542-580 and 612-687 and forms another five-stranded b-sheet with two flanking helices.
We next prepared the entire S. cerevisiae (Sc) head module by coexpressing its seven subunits in Escherichia coli (see Methods and Supplementary Fig. 2c ). The purified module (Fig. 2a) supported activator-and promoter-dependent transcription from three different promoters in vitro (Fig. 2b and Supplementary Note 1) . Crystals of the Sc head module were obtained in 2007, but persistently diffracted to low resolution. We therefore prepared the head module from Sp (Supplementary Fig. 2d ). The purified module (Fig. 2a) did not crystallize, but crystals were obtained for a variant lacking three non-essential parts, Med6 residues 181-216, Med17 residues 1-76 and Med20 ( Fig. 2a and Supplementary Fig. 2e) .
We determined the Sp head module structure de novo by multiple isomorphous replacement with anomalous scattering (see Methods and Supplementary Fig. 4a ). Modelling required selenomethionine sequence markers ( Supplementary Fig. 4b ) and the four available structures of subcomplexes ( Supplementary Fig. 5a -e). Diffraction data to 3.4 Å resolution (Supplementary Table 2 ) resulted in excellent electron density ( Supplementary Fig. 4c, d ) and a refined structure that has a free R factor (R free ) of 25.8% (Supplementary Table 2 ) and contains 87% of the residues in the variant.
The Sp head module structure reveals an asymmetric multiprotein assembly that resembles the head of a crocodile with one limb (Figs 2c  and 3a) . The structure reveals all folds and previously unobserved regions, and is partitioned into eight elements (Fig. 3a, b) . The neck submodule is formed by Med6, Med8 and parts of Med11, Med17 and Med22, and consists of 'spine', 'shoulder', 'arm' and 'finger' elements (Fig. 3a, b and Supplementary Figs 6-8 ). The spine comprises seven helices, six forming a long bundle (Med8 a5, Med17 a3, Med11N-Med22N (ref. 12)), and a seventh perpendicular helix (Med8 a4). The arm consists of a short four-helix bundle (Med6 a5, Med8 a1/2, Med17 a1), two pairs of helices (Med17 g1/a2, Med8 a29/a3), and a two-stranded sheet (Med8 b1, Med17 b1). The arm binds the shoulder, which consists of the Med6 core (Fig. 1a) . The finger is an exposed C-terminal b-hairpin in Med6 (Fig. 3a, d) Both jaws are connected to the spine. The fixed jaw is connected via the 'joint' that contains a four-stranded b-sheet formed by Med17 residues 215-259, and short linkers in Med11 and Med22. The joint may change its structure as it contains many conserved glycine and serine residues. Deletion of the Med17 part of the joint did not cause lethality in yeast, but essentially abolished activated transcription in vitro ( Supplementary Fig. 9a, b) . The moveable jaw binds the spine via Med8C, a helix extending from the Med18-Med20 heterodimer 14 ( Fig. 3a, d) , and also contacts the joint and tooth. Conservation of the module surface is highest at the shoulder and arm ( Fig. 3c and Supplementary Fig. 6 ), probably because this region binds the middle module 15, 16 . Deletion of the shoulder caused lethality ( Supplementary  Fig. 9c ).
We prepared a homology model for the Sc head module based on our structures of the Sp module and the Sc subcomplexes Med17C-Med11C-Med22C, Med11N-Med22N (ref. 12 ) and Med8C-Med18-Med20 (ref. 11). After minor adjustments, the model explained the published electron density and selenium positions 10 ( Supplementary  Fig. 10a ). Compared with the published model 10 , four a-helices were swapped, a b-sheet was added in the tooth, and the amino acid register was adjusted for 46% of the residues outside the moveable jaw (Supplementary Fig. 10b ). Thus the structures of the Sp and Sc head modules are well conserved although the structured regions show only 15% sequence identity (Supplementary Fig. 1 ). Sc-specific differences are found in six helices; three are shorter (Med8 aC, Med17 a5, Med22 a1), one is longer (Med11 a1) and two are rotated (Med17 a7, Med22 a3) ( Supplementary Fig. 5b, d, e) . Because of poor electron density 10 , the revised Sc model lacks the joint, part of the arm, the sheet in the shoulder, the finger and five protein linkers.
Structural comparisons reveal flexibility within the head module. The position of the shoulder changes in different Sp module crystals ( Supplementary Fig. 11a ), owing to a flexible connection to Med6 helix a5 (Supplementary Figs 3 and 5c ). The finger is mobile in the free Med6 structure. Flexibility of the moveable jaw is indicated by high B-factors ( Supplementary Fig. 11b and Supplementary Note 2) and electron microscopic results 17 . Movement of the nose with respect to the tooth is revealed by comparison of the Sc model with the free fixed jaw structure ( Supplementary Fig. 11c ). Comparison of the Sp structure with the Sc model indicates that the neck can rotate with respect to the jaws ( Supplementary Fig. 11e ). The rotation may be accommodated by the joint, which uses conserved hydrophobic residues to anchor the tooth to the spine. Thus the head module contains at least four mobile peripheral elements, the shoulder, finger, moveable jaw and nose.
To explain the phenotypes of known mutations, we mapped 47 sites of 55 Sc head module mutations onto the Sp structure (Fig. 4 , Supplementary Fig. 1 and Supplementary Table 3 ). Most temperaturesensitive mutations map to protein cores or domain interfaces and apparently influence module stability (Fig. 4a) . These include mutant srb4-138 that contains six Med17 mutations required for temperature sensitivity 18 , including mutations Ser226Pro and Phe649Ser that apparently destabilize the arm and nose, respectively. The human MED17 mutation Leu371Pro (residues 504 and 389 in Sc and Sp, respectively) is associated with infantile cerebral atrophy 3 and perturbs MED17 helix a5 in the tooth. The temperature-sensitive phenotype for Med11 mutations Glu17Lys/Leu24Lys (ref. 12), Leu66Pro (refs 12, 19) , and Glu92Ser (refs 12, 19) is also explained by fold destabilizations. The mutation med6-ts1 and mutations in the med6-ts6 allele 20 may destabilize the shoulder. Mutant med6-ts2 contains six point mutations 20 , of which Gln49Leu changes the conserved surface implicated in binding other Mediator parts, Phe125Tyr changes the shoulder-arm interface, and Phe194Leu may destabilize the finger-spine interface.
The structure also explains how mutant phenotypes are suppressed by secondary mutations. The SRB4-101 mutation Glu286Lys rescues the med6-ts2 phenotype 20 , apparently by creating a new salt bridge between Med17 helix a3 and Med6 helix a5. The MED6-101 mutation 21 may suppress the srb4-138 phenotype because mutation Asp152Tyr between the shoulder and arm compensates for decreased stability of the neck. The SRB6-201 (ref. 21) mutation Asn59His may also suppress the srb4-138 phenotype by stabilizing the neck.
Other genetic data implicate the fixed jaw in interactions with Pol II (Fig. 4b, Supplementary Fig. 1 and Supplementary Table 3 ). The head module interacts with Pol II near subunit Rpb3, and this contact is required for regulated transcription 22, 23 . Mutations causing co-lethality with the Rpb3 mutation rpb3-2 map to the fixed jaw (Fig. 4b) . Mutants med17-208 and med17-257 both contain the mutation Glu669Asp that is located on the nose surface and may abolish the head-polymerase interaction that is weakened by Rpb3 mutation. Mutant med17-sup1 rescues the phenotype of Rpb3 mutation Ala159Gly (ref. 22 ) and contains two mutations in the fixed jaw (Fig. 4b) . Consistent with an interaction between the head module and the Pol II region around 
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Rpb3, a mutation in the adjacent polymerase dock domain has a coldsensitive phenotype that is rescued by SRB mutations 24 in the joint and moveable jaw ( Supplementary Fig. 12, rpb1-14) . Mutants med17-68, med17-158 and med17-327 all contain mutations that are predicted to destabilize the fixed jaw.
Mediator also interacts with the carboxy-terminal domain (CTD) 4, 25 that extends from the polymerase core near the dock domain (Supplementary Fig. 12 ). CTD truncation causes a cold-sensitive phenotype that is rescued by mutations 24, 26, 27 that map mainly to the joint (Fig. 4b) . The mutation SRB4-1 maps to the joint-tooth interface, whereas the mutation SRB6-1 may stabilize the spine and adjacent joint. The mutation SRB5-1 in Med18 helix a1 may strengthen joint interaction with the moveable jaw, whereas mutation SRB2-1 alters the moveable jaw surface. These results suggest that the joint and moveable mutations that may influence module stability. Mutations were mapped onto the Sp head module structure using alignments shown in Supplementary Fig. 1 . Ca atoms of mutated residues are shown as spheres. Mutations that may affect intrasubunit stability, intersubunit stability or with uncertain affects are in yellow, dark red or cyan, respectively. b, Location of sites of Sc mutations that may influence interactions with the Pol II core, CTD and TFIIH. Mutations were mapped on the Sp head module using alignments shown in Supplementary Fig. 1 .
METHODS SUMMARY
To enable heterologous co-expression of head module subunits and their variants in E. coli, more than 300 expression vectors were tested. Expression vectors used in this work are shown in Supplementary Fig. 2 . All proteins were expressed in E. coli BL21(DE3)RIL cells and purified by nickel affinity, anion exchange and sizeexclusion chromatography. Crystals were grown by vapour diffusion at 20 uC. Sp Med6 crystals were grown using reservoir solutions containing 100 mM HEPES, pH 7.5, and 400 mM sodium citrate or 16% (v/v) tacsimate for native or selenomethionine-labelled protein, respectively. Sc Med17C-Med11C-Med22C crystals were grown in 100 mM MES, pH 6.0, and 4 M ammonium acetate. Sp head module crystals were grown in 50 mM MES, pH 6.0, and 1 M ammonium sulphate. Diffraction data were collected under cryo-conditions at Swiss Light Source (SLS) beamlines X06SA and X06DA. The Med6 and Med17C-Med11C-Med22C structures were solved using selenomethionine labelling and single-wavelength anomalous dispersion phasing. The head module structure was solved by MIRAS using tantalum and ytterbium derivatives and 23 anomalous difference Fourier peaks in a selenomethionine-labelled crystal as sequence markers. Yeast nuclear extract preparation and transcription assays were performed as described 12, 30 .
Full Methods and any associated references are available in the online version of the paper.
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Vectors and sequences. To enable heterologous co-expression of head module subunits and their variants in E. coli, more than 300 expression vectors were tested. Vectors used in this work are shown in Supplementary Fig. 2 . Vectors containing a single T7 promoter are based on pET21, pET24 or pET28 vectors (Novagen). Vectors containing two T7 promoters are based on Duet vectors (Novagen). The head co-expression vector that contains three T7 promoters was constructed by concatenating two Duet vectors. Open reading frames (ORFs) were cloned sequentially into vectors. For polycistronic constructs, ribosomal-binding sites were introduced as described 15 . Sequences of all constructs are available on request. All proteins were expressed in E. coli BL21(DE3)RIL (Stratagene). Cells were grown in LB medium at 37 uC to an attenuance (D) of 0.5 at 600 nm. Expression was induced with 0.5 mM isopropyl-b-D-thiogalactoside (IPTG) for 16 h at 18 uC. Sequence alignments were performed with MUSCLE 31 and manually adjusted based on the presented structures. Graphical representation in Supplementary Fig. 1 was generated with ESPript 32 . Sp Med6 crystal structure determination. For expression of Sp Med6 (residues 9-180), cells were transformed with the vector depicted in Supplementary Fig. 2a and the protein was purified as described 12 except that a HiLoad 16/600 Superdex 200 pg (GE Healthcare) was used for size exclusion chromatography. Crystals were grown at 20 uC in hanging drops over reservoirs containing 100 mM HEPES, pH 7.5, and 400 mM sodium citrate. For crystallization of selenomethioninelabelled 33 protein, sodium citrate was replaced by 16% (v/v) tacsimate. Crystals were collected, cryo-protected by gradually adding glycerol to a final concentration of 30% (v/v), and flash-frozen in liquid nitrogen. Native and selenomethione single-wavelength anomalous dispersion (SAD) diffraction data were collected at 100 K on a PILATUS 6M detector at the X06SA beamline at Swiss Light Source (SLS), Villigen, Switzerland. Data were processed with XDS and XSCALE 34 . Phenix.autosol 35 was used to detect selenium sites, phase the structure, perform density modification, and for initial model building. The model was manually adjusted using COOT 36 and refined with Phenix.refine 35 , including high-resolution data 37 because the resulting final model had a better R free value and stereochemistry. The refined structure has an R free value of 21.7% and shows very good stereochemistry (Supplementary Table 1 ). Ninety-six per cent of the residues fall in favoured regions of the Ramachandran plot and none of them is in disallowed regions 38 . Sc Med17C-Med11C-Med22C crystal structure determination. Sc Med17C-Med11C-Med22C was expressed in cells co-transformed with the two vectors depicted in Supplementary Fig. 2b and was purified as Sp Med6 above. For the Med11C-Med22C fusion construct, a linker with sequence GAGSGAGSG was inserted between the C terminus of Med11 and residue 96 of Med22. This covalent linker was essential for complex stability. Crystals were grown at 20 uC in hanging drops over reservoirs containing 100 mM MES, pH 6.0, and 4 M ammonium acetate. Crystals were collected, transferred to a solution containing 100 mM MES, pH 6.0 and 5 M ammonium acetate, and flash-frozen in liquid nitrogen. Selenomethionine labelling and diffraction data collection were as above for Sp Med6. Data were processed with XDS and XSCALE 34 . SHELXC/D/E 39 was used to detect selenium sites, phase the structure, and perform density modification. The resulting electron density map allowed for building of most of the model with COOT 36 . The model was refined with Phenix.refine 35 , including high-resolution data 37 because the resulting final model had a better R free value and stereochemistry. The refined structure has a R free value of 23.3% and shows very good stereochemistry (Supplementary Table 1 ). Ninety-six of the residues fall in favoured regions of the Ramachandran plot and none of them is in disallowed regions 38 . Preparation of recombinant Sc head module. Sc head module was expressed in cells transformed with the single vector depicted in Supplementary Fig. 2c . Cells were lysed by sonication in buffer A (50 mM HEPES-potassium hydroxide, pH 7.5, 400 mM potassium chloride, 10% (v/v) glycerol, 5 mM dithiothreitol (DTT)) containing protease inhibitors 12 . After centrifugation, the supernatant was loaded onto a 1 ml HisTrap column (GE Healthcare) equilibrated in buffer B (50 mM HEPES-potassium hydroxide, pH 7.5, 500 mM potassium acetate, 10% (v/v) glycerol, 50 mM imidazole, 5 mM DTT). The complex was eluted with a linear gradient from 50 mM to 300 mM imidazole in buffer B. The Sc head module was further purified by anion exchange chromatography with a 1 ml HiTrap Q HP column (GE Healthcare). The column was equilibrated in buffer C (50 mM HEPES-potassium hydroxide, pH 7.5, 150 mM potassium acetate, 10% (v/v) glycerol, 2 mM DTT), and proteins were eluted with a linear gradient from 150 mM to 1.25 M potassium acetate in buffer C. Fractions containing head module were applied to a HiLoad 16/600 Superdex 200 pg (GE healthcare) size exclusion column equilibrated in buffer D (20 mM HEPES-potassium hydroxide, pH 7.5, 150 mM potassium acetate, 10% (v/v) glycerol, 2 mM DTT). The Sc head module was concentrated to 5 mg ml 21 , flash-frozen, and stored at 280 uC. The identity of the polypeptides was confirmed by mass spectrometry. Static light scattering showed that the complex contains one copy of each subunit (not shown). The Sc head module variant lacking the Med17 part of the joint (Med17 D321-369 ) was expressed and purified the same way. Yeast strains and functional assays. Plasmids pRS316-SRB4 and pRS316-MED6 were generated by cloning the respective ORF plus 500 base pairs (bp) upstream and 300 bp downstream sequence into pRS316 (ATCC; URA3 marker). Plasmids pRS315-SRB4, pRS315-srb4 ts , pRS315-med17 D321-369 , pRS315-MED6, pRS315-med6 and pRS315-med6 were generated by cloning the respective wild-type or mutant ORF plus 500 bp upstream and 300 bp downstream sequence into pRS315 (ATCC; LEU2 marker). The heterozygous MED17/med17D and MED6/med6D Sc yeast strains were obtained from Euroscarf and transformed with pRS316-SRB4 and pRS316-MED6, respectively. Diploids were sporulated, tetrads were dissected and analysed, and a shuffle strain was selected. To assess functionality of mutants, pRS315 constructs were transformed into the respective shuffle strain. Equal amounts of freshly grown yeast cells in SC (2Ura 2Leu) medium were resuspended in water and tenfold dilutions were spotted on 5-fluoroorotic acid (5-FOA) and SC (2Ura 2Leu) plates. Isogenic SRB4 and srb4 ts strains used for nuclear extract preparation were obtained by transforming the MED17 shuffle strain with plasmids pRS315-SRB4 or pRS315-srb4 ts and streaking transformants twice on 5-FOA plates. Nuclear extracts were prepared from 3 l of yeast cultures as described 12, 30 . In vitro transcription and analysis by primer extension were performed as described 12 . Primer extension was done using the same 59-Cy5-labelled oligonucleotide (59-TTCACCAGTGAGACGGGCAAC-39) for all promoters tested. For activated transcription we added 200 ng of recombinant fulllength Gcn4 that was purified as described 40 . HIS4 and TMT1 template plasmids were as described 40 . The ACT1 template plasmid was generated by inserting the ACT1 promoter sequence (425 bp upstream to 24 bp downstream of the start codon) in pBluescript KS1 with HindIII and BamHI. Preparation of recombinant Sp head module. The complete Sp head module was expressed in cells co-transformed with the three plasmids depicted in Supplementary Fig. 2d . The crystallized Sp head module was expressed in cells co-transformed with the three plasmids shown in Supplementary Fig. 2e . Cells were lysed by sonication in buffer E (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10% (v/v) glycerol, 5 mM DTT) containing protease inhibitors 12 . After centrifugation, the supernatant was precipitated with 35% (v/v) saturated ammonium sulphate, and pellets were resuspended in buffer E and loaded on a 2 ml Ni-NTA agarose beads column (QIAGEN) equilibrated in buffer E. The flow-through was reloaded on another 2 ml Ni-NTA column and both columns were washed with buffer E containing increasing concentration of imidazole (0, 10 and 20 mM). The complex was eluted from both columns with buffer E containing 300 mM imidazole. The His-tag was cleaved overnight with 0.7 U thrombin (Sigma-Aldrich) per mg of protein while dialysing against buffer F (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM DTT). The complex was further purified by anion exchange chromatography using a 1 ml HiTrap Q HP column (GE Healthcare) equilibrated in buffer G (20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10% (v/v) glycerol, 2 mM DTT) and eluted with a linear gradient from 50 mM to 500 mM NaCl in buffer G over 70 column volumes. Fractions containing the complex were collected and applied to a HiLoad 16/600 Superdex 200 pg (GE Healthcare) size exclusion column equilibrated in buffer F. The Sp head module was concentrated to 6 mg ml 21 , flash-frozen and stored at 280 uC. The identity of the polypeptides was confirmed by mass spectrometry. Crystal structure determination of Sp Mediator head module. Crystals of the native complex were grown at 3.5 mg ml 21 Sp head module at 20 uC in hanging drops over reservoirs containing 50 mM MES, pH 6.0, and 1 M ammonium sulphate. Crystals were collected and transferred in a stepwise manner to the final cryo-solution (50 mM MES, pH 6.0, 100% saturated lithium sulphate) and flashfrozen in liquid nitrogen. For structure solution native crystals were derivatized with Ta 6 Br 12 (refs 41-43) (Proteros biostructures) and Yb-DTPA-BMA 44 (NatXray). Ta 6 Br 12 was added directly to the crystallization drop at 2 mM for 1 h. Yb-DTPA-BMA was added to the final cryo-solution at 100 mM for 10 min and back-soaked 10 s before freezing. The Sp head module was further labelled with selenomethionine as described 33 . Crystals of the labelled protein were grown at 2 mg ml 21 Sp head module at 20 uC in hanging drops over a reservoir composed of 50 mM MES, pH 6.0, 0.95 M ammonium sulphate. Crystals were measured at 100 K at SLS, Villigen, Switzerland. Diffraction data were collected on a PILATUS 6M detector at the X06SA beamline (native crystals and Ta 6 Br 12 and Yb-DTPA-BMA derivatives) or on a PILATUS 2M detector at the X06DA beamline (selenomethionine-labelled crystals). Data were processed with XDS and XSCALE 34 . The HySS submodule in Phenix 35 identified four heavy-atom sites in the Ta 6 Br 12 derivative and a single heavy-atom site in the Yb-DTPA-BMA derivative. These sites were used as input for MIRAS phasing with autoSHARP 45 . Density modification was performed with Resolve 46 and yielded an interpretable electron density map. In parallel, an anomalous difference Fourier map was calculated with data from selenomethionine-labelled crystals and with experimental MIRAS phases. The experimental map, in combination with the selenomethionine RESEARCH LETTER sequence markers, allowed the unambiguous manual fitting of the amino-terminal part of Med6 (residues 10-117) and of the Med8C-Med18 subcomplex (PDB code 3C0T). Guided by our knowledge of the folds and topologies of the Med11N-Med22N and Med17C-Med11C-Med22C subcomplexes, we could build a polyalanine model corresponding to all remaining secondary structure elements with COOT 36 . MIRAS phases were then combined with phases from this initial model and density was modified using the AutoBuild routine in Phenix 35 . This led to an improved electron density map that allowed for an extension of the initial model. This process was iterated until no further improvement of the map was observed. Then, 23 selenium sites were identified and used as input for SAD phasing with the AutoSol routine in Phenix 35 . The new phases were combined with phases from the partial model. After density modification, an electron density map of excellent quality was obtained, in which many side chains and most of the linkers between secondary structure elements were visible. After rebuilding, the model was refined with autoBUSTER 47 . The resulting 2F o 2 F c electron density map allowed further improvement of the model. After several rounds of rebuilding and refinement with autoBUSTER and Phenix.refine 35 using individual B-factor and TLS refinement, we obtained the final model, which shows good stereochemistry and an R free value of 25.8% (Supplementary Table 2 ). Including high-resolution data 37 resulted in a refined structure with better R free values and stereochemistry. More than 95% and 99% of the residues fall in favoured and allowed regions of the Ramachandran plot, respectively 38 .
Modelling of the Sc Mediator head module. A hybrid model was build using our structure of Sc Med17C-Med11C-Med22C and the structure of Sc Med8C-Med18-Med20 (ref. 11) as models for the fixed and moveable jaws, respectively. For the neck, our Sp head module was used, replacing Med11N and Med22 helix a1 with the corresponding Sc elements in the Sc Med11N-Med22N structure 12 .
Other amino acids of the neck were replaced with their Sc counterparts, based on sequence alignments. Hydrophobic character of the amino acid situated in the core in the resulting neck model was systematically checked. The obtained models for the two jaws, the spine and the shoulder were separately fitted onto the corresponding elements in the published architectural model of the Sc head module 10 (PDB code 3RJ1), using secondary structure matching in COOT 36 . This resulted in a model that explained most of the published electron density. Regions of the model that lacked convincing density were removed, as well as side-chain atoms.
The resulting model was adjusted by rigid-body refinement with Phenix.refine 35 , using the six structural elements present in the model (partial shoulder, partial arm, spine, tooth, nose and moveable jaw) as separate rigid-body groups. For figure preparation and structure interpretation, Sp Med20 was modelled with MODELLER 48 .
